STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

URL has been copied successfully!

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

We have some news out of a meeting of the European Society of Cardiology, Roivant won a key autoimmune drug approval, and former Stanford president Marc Tessier-Lavigne is pushing back against revived allegations of research fraud.

RIP to Yayoi Kusama. Wearing manic polka dots today in tribute.

Continue to STAT+ to read the full story…

Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here